Kerstin Luhn-Wegmann

Title: The Innovative Contributions of Kerstin Luhn-Wegmann

Introduction

Kerstin Luhn-Wegmann is a notable inventor based in Leiden, Netherlands. She has made significant contributions to the field of immunology, particularly in the development of vaccines. Her work focuses on enhancing immune responses to combat serious diseases.

Latest Patents

Kerstin holds a patent for the MVA-BN and Ad26.ZEBOV or Ad26.filo prime-boost regimen. This patent describes compositions and methods for generating an improved effective immune response against immunogens in humans. The enhanced immune response is achieved by utilizing an MVA vector as a prime, followed by an adenovirus vector as a first boost, and another adenovirus vector as a second boost. These compositions and methods aim to provide protective immunity against diseases, including infections from various subtypes of Ebola and Marburg filoviruses.

Career Highlights

Throughout her career, Kerstin has worked with prominent organizations in the vaccine development sector. She has been associated with Janssen Vaccines & Prevention B.V. and Bavarian Nordic A/S. Her expertise and innovative approaches have contributed to advancements in vaccine technology.

Collaborations

Kerstin has collaborated with various professionals in her field, including Benoit Christophe Stephan Callendret. These partnerships have facilitated the exchange of ideas and fostered innovation in vaccine research.

Conclusion

Kerstin Luhn-Wegmann's contributions to immunology and vaccine development are noteworthy. Her innovative patent and collaborations highlight her commitment to enhancing public health through scientific advancements.